Medchart
PrivateLast Round
Series A
Dec 1, 2020
Total Funding Raised
$26.06M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Medchart operates in Healthcare & Life Sciences and is based in Toronto, Ontario. Its latest recorded funding round was a Series A round in December 2020.
Medchart is a healthtech company that provides a privacy-compliant platform designed to automate medical record release and consent capture.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, Legal Tech, InsurTech, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medchart Comparables
Compare Medchart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Codes Health | 80% | |
| YoCierge | 79% | |
| ChartSquad | 77% |
For institutional investors. Book with your work email.
Medchart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 1, 2020 | ||||
| Series A | Dec 1, 2020 | ||||
| Grant | Jan 4, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Medchart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Crosslink Capital | Series A |
| Stanford Law School | Series A |
| iGan Partners | Series A, Seed |
| Silicon Valley Bank | Series A |
| Vast Ventures | Series A |
| Golden Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 125, 31.3x the trailing average.
- Jul 13, 2026
Open roles increased from 0 to 12, representing 27% of headcount.
For institutional investors. Book with your work email.
Medchart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medchart's valuation, stock price, and market status.
Is Medchart a public or private company?
Medchart is a private company.
What is the current stock price of Medchart?
Medchart is a private company, so its shares have no public market price. Caplight tracks Medchart's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medchart worth (valuation)?
Valuation information for Medchart is not publicly available.
Can I buy Medchart stock?
Medchart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medchart's last funding round?
Medchart's most recent funding round was Series A on December 1, 2020.
Who are the main investors in Medchart?
Key investors in Medchart include Crosslink Capital, Golden Ventures.
Will Medchart IPO soon?
No public IPO plans have been announced for Medchart.
How can I track Medchart secondary market activity?
Caplight tracks bids, offers, and trades in Medchart's shares on secondary markets.